Clinical Trial Update: Trial Evaluating the Efficacy and Safety of Oral Vadadustat Once Daily (QD) and Three Times Weekly (TIW) for the Maintenance Treatment of Anemia in Hemodialysis Subjects Converting From Erythropoiesis-Stimulating Agents (ESAs) [Phase 3]

View source ↗

Summary

This ClinicalTrials.gov update reports on a Phase 3 trial evaluating the efficacy and safety of oral vadadustat once daily or three times weekly for maintenance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• Vadadustat (vadadustat)

Snippet

Sponsor: Akebia Therapeutics | Conditions: Anemia | Phase 3 | Status: COMPLETED | Results posted: 2025-05-22